AMANTA HEALTHCARE LIMITED Share Price

AMANTA HEALTHCARE LIMITED Share Price

NSE: AMANTA
|
Pharmaceuticals
|
S Cap
₹ 190.23
+₹3.73 (2.00%)
1D
Last updated 03 Sep, 2026, 15:15 IST

AMANTA HEALTHCARE LIMITED Share Price Today

As of 4 Sep 2026, AMANTA HEALTHCARE LIMITED share price is ₹190.23. The stock opened at ₹190.23, compared to its previous close of ₹186.50. During today's trading session, AMANTA HEALTHCARE LIMITED share price moved in the range of ₹190.23 to ₹190.23, with an average price of ₹190.23 for the day. Looking at its last 52-week, the stock has touched a low of ₹92.00 and a high of ₹205.57.

₹190.23
2.00% up today
₹190.23
1D LOW
1D HIGH

AMANTA HEALTHCARE LIMITED Returns Calculator

Circuit
L
H
₹182.77
₹190.23
52-week
L
H
₹92.00
₹205.57

About AMANTA HEALTHCARE LIMITED

AMANTA HEALTHCARE LIMITED Share Price
ISIN
INE084K01015
Sector Market Cap
₹ 727.27 Cr

Amanta Healthcare Ltd is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing and marketing a diverse range of sterile liquid products-parenteral products, being packed in plastic containers with Aseptic Blow-Fill-Seal (ABFS) and Injection Strech Blow Molding (ISBM) technology. The Company manufactures large volume parenteral (LVPs) and small volume parenteral (SVPs) in six therapeutic segments. In addition to that, it also manufactures medical devices. The Company manufactures fluid therapy- (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions in the therapeutic segment and products like irrigation, first-aid solutions, eye lubricants in the medical device segment. It also offers a various range of closure systems, such as nipple head, twist-off, leur-lock and screw types and container fill-volume ranging from two milliliters (ml) to 1000 ml.

AMANTA HEALTHCARE LIMITED Financial Highlights

  • Revenue: AMANTA HEALTHCARE LIMITED reported revenue of ₹291.05 crore in FY26 vs ₹276.10 crore in FY25. It showed an increase of 5.41% on a yearly basis.
  • Operating Profit: AMANTA HEALTHCARE LIMITED reported an operating profit of ₹21.12 crore in FY26 vs ₹14.71 crore in FY25. It showed an increase of 43.58% on a year-on-year basis.
  • Net Profit: AMANTA HEALTHCARE LIMITED reported a net profit of ₹14.88 crore in FY26 vs ₹10.50 crore in FY25. It showed an increase of 41.71% on a yearly basis.

AMANTA HEALTHCARE LIMITED Quarterly Result Highlights

  • AMANTA HEALTHCARE LIMITED reported revenue of ₹69.44 crore in Jun 2026, compared with ₹78.65 crore in Mar 2026, representing a decrease of 11.71% on a quarter-on-quarter (QoQ) basis.
  • AMANTA HEALTHCARE LIMITED reported an operating profit of ₹4.49 crore in Jun 2026, compared with ₹7.62 crore in Mar 2026, representing a decrease of 41.08% on a quarter-on-quarter (QoQ) basis.
  • AMANTA HEALTHCARE LIMITED reported a profit of ₹3.31 crore in Jun 2026, compared with ₹5.53 crore in Mar 2026, reflecting a decrease of 40.14% on a QoQ basis.
  • The earnings per share (EPS) of AMANTA HEALTHCARE LIMITED stood at ₹4.33 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
63.80%
FII
0.43%
Other DII
7.59%
Retail and other
22.85%
Mutual funds
5.33%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20251.00%
Dec 20251.10%
Mar 20260.85%
Jun 20260.43%
Mkt Cap Cr
727.27
P/E
49.55
P/B
3.30
ROE
7.46%
D/E
1.11
ROCE
9.58%
Div. Yield
0.00%
EPS(TTM)
4.33
Turnover
0.52
EV/EBITDA
14.85
Net Margin
5.69%
Op. Margin
21.94%
ROA
2.63%
Quick Ratio
1.10
Curr. Ratio
3.58
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Amanta Healthcar outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Amanta Healthcar appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,791.0037.705.4713.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,45,081.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,90,351.0086.8922.2825.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,14,833.0024.654.1818.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,163.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,431.0017.594.3523.76%0.0424.88%659.000.84%0.57129.18
Mankind Pharma98,304.7046.845.9411.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Aurobindo Pharma95,299.8025.682.529.25%0.1911.76%394.820.24%0.3841.58

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

AMANTA HEALTHCARE LIMITED Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹287.68₹274.71₹280.34₹259.13
Other Income₹3.37₹1.39₹1.27₹3.57
Total Revenue₹291.05₹276.09₹281.61₹262.70
Total Expenses₹267.29₹261.39₹276.22₹260.01
Profit Before Tax₹21.12₹14.71₹5.39₹2.69
Tax₹6.25₹4.21₹1.76₹4.80
Profit After Tax₹14.88₹10.50₹3.63-₹2.11
EPS - Basic₹4.33₹3.71₹1.35-₹0.79
EPS - Diluted₹4.33₹3.71₹1.35-₹0.79

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹21.12₹14.71₹5.39₹2.69
Income before WC changes₹61.91₹61.47₹59.05₹52.82
Change in Assets-₹15.63-₹16.27₹13.01-₹5.23
Change in Liabilities₹9.23₹5.22-₹8.03₹1.30
Change in WC-₹6.40-₹11.05₹4.97-₹3.93
Cash flow from Operations₹48.45₹46.62₹58.07₹42.58
Cash flow from Investing-₹93.61-₹24.47-₹10.32-₹6.53
Cash flow from Financing₹125.95-₹23.47-₹46.32-₹42.32
Total Cash Flow₹80.79-₹1.32₹1.43-₹6.27
Cash (Start of the year)₹0.22₹1.54₹0.11₹6.38
Cash (End of the year)₹81.01₹0.22₹1.54₹0.11

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹319.45₹243.84₹234.23₹243.06
Current Assets₹238.53₹137.92₹117.89₹131.01
Total Assets₹557.98₹381.76₹352.12₹374.06
Current Liabilities₹141.06₹115.08₹101.66₹97.13
Net Current Asset₹97.47₹22.84₹16.23₹33.87
Non-Current Liabilities₹196.71₹170.29₹184.17₹214.04
Equity Capital₹220.21₹96.39₹66.29₹62.88
Total Equity & Liabilities₹557.98₹381.76₹352.12₹374.06
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
59.67
Neutral
ATR (14)
7.75
Neutral
STOCH(9,6)
30.59
Neutral
STOCH RSI (14)
33.41
Neutral
ADX(9)
33.17
Bearish
UO(9)
55.07
Neutral
ROC(12)
10.41
Bullish
WillR(14)
-27.61
Neutral
Period
Simple value
Exponential vaue
5D
188.13
188.84
10D
191.48
187.1
20D
178.49
182.01
50D
172.29
170.81
100D
154.07
156.32
Volume trend — traded volume by day
3 Sep0L
2 Sep0L
1 Sep0L
31 Aug0L
28 Aug0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
AMANTA HEALTHCARE LIMITED Share Price
AMANTA HEALTHCARE LIMITED
Pharmaceuticals
Add Stock
Add Another

AMANTA HEALTHCARE LIMITED Share Price FAQs

AMANTA HEALTHCARE LIMITED share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837